Matches in Wikidata for { <http://www.wikidata.org/entity/Q89589016> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- Q89589016 description "2020 nî lūn-bûn" @default.
- Q89589016 description "2020 թվականին հրատարակված գիտական հոդված" @default.
- Q89589016 description "2020年の論文" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年学术文章" @default.
- Q89589016 description "2020年學術文章" @default.
- Q89589016 description "2020年學術文章" @default.
- Q89589016 description "2020年學術文章" @default.
- Q89589016 description "2020年學術文章" @default.
- Q89589016 description "2020年學術文章" @default.
- Q89589016 description "2020년 논문" @default.
- Q89589016 description "article científic" @default.
- Q89589016 description "article scientific" @default.
- Q89589016 description "article scientifique" @default.
- Q89589016 description "articol științific" @default.
- Q89589016 description "articolo scientifico" @default.
- Q89589016 description "artigo científico" @default.
- Q89589016 description "artigo científico" @default.
- Q89589016 description "artigo científico" @default.
- Q89589016 description "artikel ilmiah" @default.
- Q89589016 description "artikull shkencor" @default.
- Q89589016 description "artikulong pang-agham" @default.
- Q89589016 description "artykuł naukowy" @default.
- Q89589016 description "artículo científico publicado en 2020" @default.
- Q89589016 description "artículu científicu" @default.
- Q89589016 description "bilimsel makale" @default.
- Q89589016 description "bài báo khoa học" @default.
- Q89589016 description "naučni članak" @default.
- Q89589016 description "scienca artikolo" @default.
- Q89589016 description "scientific article published in January 2020" @default.
- Q89589016 description "scientific article published in January 2020" @default.
- Q89589016 description "scientific article published on 01 January 2020" @default.
- Q89589016 description "teaduslik artikkel" @default.
- Q89589016 description "tieteellinen artikkeli" @default.
- Q89589016 description "tudományos cikk" @default.
- Q89589016 description "vedecký článok" @default.
- Q89589016 description "vetenskaplig artikel" @default.
- Q89589016 description "videnskabelig artikel udgivet januar 2020" @default.
- Q89589016 description "vitenskapelig artikkel" @default.
- Q89589016 description "vitskapeleg artikkel" @default.
- Q89589016 description "vědecký článek" @default.
- Q89589016 description "wetenschappelijk artikel" @default.
- Q89589016 description "wissenschaftlicher Artikel" @default.
- Q89589016 description "επιστημονικό άρθρο" @default.
- Q89589016 description "мақолаи илмӣ" @default.
- Q89589016 description "наукова стаття, опублікована в січні 2020" @default.
- Q89589016 description "научна статия" @default.
- Q89589016 description "научная статья" @default.
- Q89589016 description "научни чланак" @default.
- Q89589016 description "научни чланак" @default.
- Q89589016 description "מאמר מדעי" @default.
- Q89589016 description "مقالة علمية نشرت في يناير 2020" @default.
- Q89589016 description "জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q89589016 description "บทความทางวิทยาศาสตร์" @default.
- Q89589016 description "სამეცნიერო სტატია" @default.
- Q89589016 name "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 name "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 name "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 type Item @default.
- Q89589016 label "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 label "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 label "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 prefLabel "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 prefLabel "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 prefLabel "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 P1104 Q89589016-C32DBC1B-4224-474D-9631-581D42C7CD52 @default.
- Q89589016 P1433 Q89589016-F2818608-F334-4BCA-AC03-E4915F3AAB9B @default.
- Q89589016 P1476 Q89589016-6BBA844A-63C8-4222-97A3-3BFF7CEA2BC6 @default.
- Q89589016 P2093 Q89589016-3B2AE2B3-C188-4EFD-B1F7-23D7CA841390 @default.
- Q89589016 P2093 Q89589016-7A1E9C51-0AB5-4940-9800-5513F1FA0271 @default.
- Q89589016 P304 Q89589016-E4D9DAF6-D3A7-4466-A813-A191FEE570D4 @default.
- Q89589016 P31 Q89589016-B031B35A-29E9-4D8B-9DAF-5C8F283FAF93 @default.
- Q89589016 P356 Q89589016-11645807-FCDD-448A-A0F3-45822369FF6F @default.
- Q89589016 P478 Q89589016-D8BBEDE6-B430-483D-ADB1-CDE32EF42283 @default.
- Q89589016 P50 Q89589016-B1739B8D-EBF9-44D2-B8F7-5F9DD35501B3 @default.
- Q89589016 P577 Q89589016-F1AC1FF1-16B1-480D-BBCD-C30702E5F782 @default.
- Q89589016 P698 Q89589016-F4B93F70-455C-470A-9312-103C4F4EA96A @default.
- Q89589016 P921 Q89589016-57B606DA-7041-49E6-96FD-6CAA0D6BE7CF @default.
- Q89589016 P921 Q89589016-67C82B07-9B9A-4E28-BF53-D64CB0189BC4 @default.
- Q89589016 P356 FMB-2019-0237 @default.
- Q89589016 P698 32030996 @default.
- Q89589016 P1104 "+22" @default.
- Q89589016 P1433 Q15759961 @default.
- Q89589016 P1476 "Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions" @default.
- Q89589016 P2093 "Bache Emmanuel Bache" @default.
- Q89589016 P2093 "Martin P Grobusch" @default.
- Q89589016 P304 "85-106" @default.
- Q89589016 P31 Q13442814 @default.
- Q89589016 P356 "10.2217/FMB-2019-0237" @default.
- Q89589016 P478 "15" @default.
- Q89589016 P50 Q47007273 @default.
- Q89589016 P577 "2020-01-01T00:00:00Z" @default.
- Q89589016 P698 "32030996" @default.
- Q89589016 P921 Q10538943 @default.
- Q89589016 P921 Q5452194 @default.